Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 5,719 $ 6,888
Trading marketable securities 8,272 9,150
Available-for-sale securities (amortized cost of $0 and $1,502, respectively) 0 1,495
Prepaid expenses and other current assets 611 789
Total Current Assets 14,602 18,322
Operating lease right-of-use assets 39 60
Intangible asset 2,039 2,039
Other assets 197 3
TOTAL ASSETS 16,877 20,424
Current Liabilities    
Accounts payable and accrued liabilities 523 905
Due to related parties 46 53
Operating lease liabilities - current portion 34 40
Total Current Liabilities 603 998
Operating lease liabilities 6 23
TOTAL LIABILITIES 609 1,021
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 416,667 shares authorized, 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022 0 0
Common Stock, par value $0.001, 50,000,000 shares authorized, as of June 30, 2023 and December 31, 2022 2,855,688 and 2,855,688 shares issued and outstanding as of June 30, 2023 and December 31, 2022 3 3
Additional paid-in capital 51,254 50,675
Accumulated deficit (34,788) (31,021)
Accumulated other comprehensive loss (201) (254)
TOTAL STOCKHOLDERS' EQUITY 16,268 19,403
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 16,877 $ 20,424